Ledger.Open graph →

SEC Form D · Amendment · filed March 6, 2023

INVO Bioscience, Inc

Offering

$500K

Sold

$500K

Exemption

Rule 506(b)

Industry

Other Health Care

Location

SARASOTA, FL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Andrea Goren · Sarasota, FLExec Barbara Ryan · Sarasota, FLDirector Michael J. Campbell · Sarasota, FLExec Trent Davis · Sarasota, FLDirector Steven Shum · Sarasota, FLExec · Director Jeffrey Segal · Sarasota, FLDirector Matthew Szot · Sarasota, FLDirector Rebecca Messina · Sarasota, FLDirector Adrian Waters · Dublin 2, IrelandDirector David K. Pearson · Houston, TXDirector Jennifer L. Bercy · Woodland Hills, CADirector Victor Kuznetsov · FORT LAUDERDALE, FLExec David E. Kass · Columbus, OHExec David Andonian · New York, NYExec · Director Emre Altinok · Brooklyn, NYDirector David K. Hiemstra · Houston, TXDirector Brett Paulk · Tomball, TXExec · Director John Galdieri Iii · ANNAPOLIS, MDExec Patrick Britton-Harr · ANNAPOLIS, MDDirector Wenyi Huang · Dallas, TXDirector Jon Bridgman · Toronto, Ontario, CanadaExec Guillaume Luccisano · Cambridge, MADirector David M. Emery · St Peter Port, Y7Director Richard A. Western · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗